Line 1: Line 1:
{{Infobox drug reference
{{Infobox drug reference
| trade_names =  
| trade_names = Pradaxa
| drug_class =  
| drug_class =  
| drug_class_color =  
| drug_class_color =  
Line 7: Line 7:
| routes =  
| routes =  
| dosage =  
| dosage =  
| mechanism = Direct thrombin inhibitor
| adverse_effects =
| time_onset =
| duration =
| metabolism =
| halflife_redistribution =
| halflife_elimination =
| clearance =
| protein_binding =
}}
}}


Line 26: Line 35:


==== Adverse effects<!-- Describe any potential adverse effects of the drug. --> ====
==== Adverse effects<!-- Describe any potential adverse effects of the drug. --> ====
* Bleeding
* Gastritis


=== Pharmacokinetics<!-- Describe the pharmacokinetics of the drug. --> ===
=== Pharmacokinetics<!-- Describe the pharmacokinetics of the drug. --> ===

Latest revision as of 17:39, 19 January 2022

Dabigatran
Trade names

Pradaxa

Clinical data
Pharmacodynamics
Mechanism of action

Direct thrombin inhibitor

Pharmacokinetics
Physical and chemical data
Article quality
Editor rating
Unrated
User likes
0

Dabigatran (Pradaxa) is a direct thrombin inhibitor.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

  • Bleeding
  • Gastritis

Pharmacokinetics

Chemistry and formulation

History

References